Monthly Archives: May 2018

New Directions In Alzheimer’s Disease Research And Development
May 15, 2018

This blog was written by Adam Rosenberg, CEO of Rodin Therapeutics, as part of the From The Trenches feature of LifeSciVC. Disappointing results in Alzheimer’s clinical trials seem to be announced on an almost monthly, and sometimes weekly basis: Merck’s

Leave a comment

Right From The Beginning: Returning To The Origins Of The Orphan Drug Movement
May 1, 2018

This blog was co-written by Doug Kerr, Head of Preclinical Research & Clinical Development, and Geoff McDonough, CEO, both of GenerationBio, as part of the From The Trenches feature of LifeSciVC. Our industry stands at the beginning of the most

Leave a comment